Literature DB >> 19306811

Portal vein embolization in hilar cholangiocarcinoma.

Martin Palavecino1, Eddie K Abdalla, David C Madoff, Jean-Nicolas Vauthey.   

Abstract

In patients with hilar cholangiocarcinoma, extended hepatectomy and caudate lobe resection are often performed to achieve an R0 resection. In patients whose standardized future liver remnant is less than or equal to 20% of total liver volume, portal vein embolization (PVE) should be performed. In patients with biliary dilatation of the future liver remnant, a biliary drainage catheter should be placed before PVE. If the planned surgery is an extended right hepatectomy, segment 4 branch embolization improves the hypertrophy of segments 2 and 3. In high-volume centers, PVE can be safely performed; it increases the resectability rate and results in the same survival rates as those in patients who undergo resection without PVE.

Entities:  

Mesh:

Year:  2009        PMID: 19306811     DOI: 10.1016/j.soc.2008.12.007

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  10 in total

1.  Hilar cholangiocarcinoma: expert consensus statement.

Authors:  John C Mansour; Thomas A Aloia; Christopher H Crane; Julie K Heimbach; Masato Nagino; Jean-Nicolas Vauthey
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

2.  Consensus conference on hilar cholangiocarcinoma.

Authors:  Christopher E Forsmark; Alessandro L Diniz; Andrew X Zhu
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

3.  Issues in surgery for hilar cholangiocarcinoma.

Authors:  Sudeep R Shah
Journal:  Indian J Surg       Date:  2011-11-29       Impact factor: 0.656

Review 4.  Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making.

Authors:  Irinel Popescu; Traian Dumitrascu
Journal:  Langenbecks Arch Surg       Date:  2014-05-20       Impact factor: 3.445

5.  Does preoperative portal vein embolization have any impact on the outcome of right-side hepatectomy for Klatskin tumor?

Authors:  Mee Joo Kang; Jin-Young Jang; Wooil Kwon; Jae Woo Park; Ye Rim Chang; Sun-Whe Kim
Journal:  J Gastrointest Surg       Date:  2013-07-09       Impact factor: 3.452

6.  Surgical resection for hilar cholangiocarcinoma: experience improves resectability.

Authors:  Robert M Cannon; Guy Brock; Joseph F Buell
Journal:  HPB (Oxford)       Date:  2011-12-12       Impact factor: 3.647

7.  ALPPS in right trisectionectomy: a safe procedure to avoid postoperative liver failure?

Authors:  Jun Li; Paolo Girotti; Ingmar Königsrainer; Ruth Ladurner; Alfred Königsrainer; Silvio Nadalin
Journal:  J Gastrointest Surg       Date:  2013-01-04       Impact factor: 3.452

8.  Evaluating the Clinical Applicability of the European Staging System for Perihilar Cholangiocarcinoma.

Authors:  Hishaam Nabil Ismael; Evelyne Loyer; Harmeet Kaur; Claudius Conrad; Jean-Nicolas Vauthey; Thomas Aloia
Journal:  J Gastrointest Surg       Date:  2016-01-22       Impact factor: 3.452

9.  Preoperative Cholangitis and Future Liver Remnant Volume Determine the Risk of Liver Failure in Patients Undergoing Resection for Hilar Cholangiocarcinoma.

Authors:  Dario Ribero; Giuseppe Zimmitti; Thomas A Aloia; Junichi Shindoh; Forchino Fabio; Marco Amisano; Guillaume Passot; Alessandro Ferrero; Jean-Nicolas Vauthey
Journal:  J Am Coll Surg       Date:  2016-02-13       Impact factor: 6.113

10.  Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma.

Authors:  Pim B Olthof; Luca Aldrighetti; Ruslan Alikhanov; Matteo Cescon; Bas Groot Koerkamp; William R Jarnagin; Silvio Nadalin; Johann Pratschke; Moritz Schmelze; Ernesto Sparrelid; Hauke Lang; Alfredo Guglielmi; Thomas M van Gulik
Journal:  Ann Surg Oncol       Date:  2020-02-26       Impact factor: 5.344

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.